Literature DB >> 6652377

The effect of exaprolol (MG 8823) on epicardial ST-segment changes in a feline model of acute myocardial ischaemia.

J R Parratt, E Udvary.   

Abstract

A model is described (anaesthetized, open-chest cats subjected to acute coronary artery occlusion) which allows the effects of drug interventions to be determined on one major electrocardiographic index of myocardial ischaemia. Epicardial ST-segment changes were continuously recorded from five individual sites on the surface of the left ventricle. Coronary artery occlusion (left anterior descending branch) resulted in marked and consistent elevations of the ST-segment in all sites in nearly all experiments. These changes started within 1 min of the onset of ischaemia and reached a peak at between 30 and 60 min; thereafter there was a gradual reduction over the next 4 h. The one significant haemodynamic effect of coronary artery occlusion was an increase in left ventricular (LV) end-diastolic pressure (LVEDP). Ventricular ectopic activity was not pronounced in this model (about 50 ectopic beats over the initial 30 min post-occlusion period). Exaprolol (1.0 mg kg-1, intravenously) a potent beta-adrenoceptor blocking agent with 'membrane stabilising activity', when given 1 h after the onset of ischaemia, reduced heart rate and LV dP/dtmax and increased LVEDP. These effects were prolonged (i.e. little recovery in heart rate 3 h after administration). Exaprolol decreased total ST-segment elevation immediately after administration; this was significantly different from the effect of intravenous saline and lasted for at least 3 h. The effects appeared to be greater at sites of less pronounced ischaemia. Intramyocardial temperature records were taken to indicate a reduction in blood flow to the ischaemic region; however the alleviation of epicardial ST-segment elevation suggests an improved myocardial oxygen demand:supply ratio. Reperfusion was unsuccessfully attempted after a 4 h occlusion period; reperfusion after a shorter period (30 min) resulted in ventricular ectopic activity but no fibrillation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6652377      PMCID: PMC2044960          DOI: 10.1111/j.1476-5381.1983.tb11054.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  20 in total

1.  Antiarrhythmic, haemodynamic and metabolic effects of 3alpha-amino-5alpha-androstan-2beta-ol-17-one hydrochloride in greyhounds following acute coronary artery ligation.

Authors:  R J Marshall; J R Parratt
Journal:  Br J Pharmacol       Date:  1975-11       Impact factor: 8.739

2.  Comparative effects of propranolol and practolol in the early stages of experimental canine myocardial infarction.

Authors:  R J Marshall; J R Parratt
Journal:  Br J Pharmacol       Date:  1976-06       Impact factor: 8.739

3.  Basic ethers of cyclohexylphenols with beta-blocking activity: synthesis and pharmacological study of exaprolol.

Authors:  M Carissimi; P Gentili; E Grumelli; E Milla; G Picciola; F Ravenna
Journal:  Arzneimittelforschung       Date:  1976-04

4.  Effect of noradrenaline and isoprenaline on blood flow in the acutely ischaemic myocardium.

Authors:  G E Moore; J R Parratt
Journal:  Cardiovasc Res       Date:  1973-07       Impact factor: 10.787

5.  Reduction by propranolol of myocardial necrosis following temporary coronary artery occlusion in dogs.

Authors:  K A Reimer; M M Rasmussen; R B Jennings
Journal:  Circ Res       Date:  1973-09       Impact factor: 17.367

6.  [Myocardial necroses after permanent or temporary coronary artery occlusion with and without heart relief by extracorporeal circulation. Enzyme histochemical and morphological studies on the cat heart in surgery of acute myocardial infarct].

Authors:  A Krug
Journal:  Arch Kreislaufforsch       Date:  1972-12

7.  Vasospastic elements in myocardial infarction following coronary occlusion in the dog.

Authors:  J Grayson; M Irvine; J R Parratt; J Cunningham
Journal:  Cardiovasc Res       Date:  1968-01       Impact factor: 10.787

8.  Factors influencing infarct size following experimental coronary artery occlusions.

Authors:  P R Maroko; J K Kjekshus; B E Sobel; T Watanabe; J W Covell; J Ross; E Braunwald
Journal:  Circulation       Date:  1971-01       Impact factor: 29.690

9.  The haemodynamic and metabolic effects of MG 8926, a prospective antidysrhythmic and antianginal agent.

Authors:  R J Marshall; J R Parratt
Journal:  Br J Pharmacol       Date:  1977-02       Impact factor: 8.739

10.  Protective action of timolol in acute myocardial ischemia.

Authors:  A M Lefer; J R Cohn; G H Osman
Journal:  Eur J Pharmacol       Date:  1977-02-21       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.